rebel Financial rebel Financial
← All Posts
QGEN

QIAGEN N.V.

June 25, 2026 • Author: Phil Ratcliff • QGEN
Item Proposal Vote
1 Proposal to adopt the Annual Accounts for the year ended December 31, 2025. ✓ For
2 Proposal to cast a favorable non-binding advisory vote in respect of the Remuneration Report 2025. ✓ For
3 Proposal to approve the proposed dividend for 2026. ✓ For
4 Proposal to discharge from liability the Managing Directors for the performance of their duties during 2025. ✓ For
5 Proposal to discharge from liability the Supervisory Directors for the performance of their duties during 2025. ✓ For
6 Appointment/Reappointment of the Supervisory Directors for a term running up to and including the date of the Annual General Meeting in 2027.
6a Dr. Toralf Haag ✓ For
6b Mr. Bert van Meurs ✓ For
6c Mr. Robert McMahon ✓ For
6d Ms. Eva van Pelt ✓ For
6e Dr. Eva Pisa ✓ For
6f Mr. Stephen H. Rusckowski ✓ For
6g Mr. Mark P. Stevenson ✓ For
6h Ms. Elizabeth E. Tallett ✓ For
7 Reappointment of the Managing Directors for a term running up to and including the date of the Annual General Meeting in 2027.
7a Mr. Thierry Bernard ✗ Against
7b Mr. Roland Sackers ✗ Against
8 Proposal to adopt an amendment to the Managing Board Remuneration Policy. ✓ For
9 Proposal to reappoint EY Accountants B. V. as auditor for the year ending December 31 , 2026. ✓ For
10 Proposal to reappoint EY Accountants B. V. as the assurance provider for the year ending December 31 , 2026. ✓ For
11 Proposal to authorize the Supervisory Board, until December 24, 2027 to:
11a issue a number of ordinary shares and financing preference shares and grant rights to subscribe for such shares of up to 10% of the aggregate par value of all shares issued and outstanding. ✓ For
11b restrict or exclude the pre-emptive rights with respect to issuing ordinary shares or granting subscription rights of up to 10% of the aggregate par value of all shares issued and outstanding. ✓ For
12 Proposal to authorize the Managing Board, until December 24, 2027, to acquire shares in the Company's own share capital. ✓ For
13 Proposal to approve discretionary rights for the Managing Board to implement a capital repayment by means of a synthetic share repurchase. ✓ For
14 Proposal to approve the cancellation of whole and/or fractional ordinary shares held by the Company. ✓ For
Attachments
📄
QIAGEN_PROXY_STATEMENT.pdf 5.3 MB
This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial's solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.